Generation and Screening of Antigen-Specific Nanobodies from Mammalian Cells Expressing the BCR Repertoire Library Using Droplet-Based Microfluidics
2022 · Analytical Chemistry · 12 citations
https://doi.org/10.1021/acs.analchem.2c00865
Q
Qumiao Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
30
Papers
748
Citations
9
h-index
9
i10-index
Qumiao Xu is an academic researcher from BGI Group (China). The author has contributed to research in topics: CAR-T cell therapy research & Cancer Immunotherapy and Biomarkers & T-cell and B-cell Immunology. The author has an h-index of 9, co-authored 26 publications.
Papers by this author
worksHigh-Throughput Screening of Functional Neo-Antigens and Their Specific T-Cell Receptors via the Jurkat Reporter System Combined with Droplet Microfluidics
2023 · Analytical Chemistry · 6 citations
https://doi.org/10.1021/acs.analchem.3c01754
EGFR and MUC1 as dual-TAA drug targets for lung cancer and colorectal cancer
2024 · Frontiers in Oncology · 4 citations
https://doi.org/10.3389/fonc.2024.1433033
Downregulation of PTPRT elevates the expression of survivin and promotes the proliferation, migration, and invasion of lung adenocarcinoma
2024 · BMC Cancer · 2 citations
https://doi.org/10.1186/s12885-024-11840-7
PcoCas12a: A novel CRISPR enzyme from Prevotella copri enhancing TCR-T-cell tumor suppression
2025 · International Journal of Biological Macromolecules · 2 citations
https://doi.org/10.1016/j.ijbiomac.2025.139740
Transcriptome profiling of tumor-infiltrating lymphocyte-mediated cytotoxicity against patient-derived lung cancer organoids
2025 · Communications Biology · 1 citations
https://doi.org/10.1038/s42003-025-09188-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat